September 16, 2026 · Baltimore, MD
Exploring the therapeutic benefits of cannabinoids for health, performance, and aging. Bridging cannabis science and clinical medicine for the communities that need it most.
Our mission
The CannaHealth Summit brings together medical experts, cannabinoid researchers, industry innovators, and real-world users to advance evidence-based applications of cannabinoids for recovery, health, and human performance.
The science of cannabinoids is advancing faster than clinical adoption. This summit exists to close that gap — with evidence, real patient voices, and honest dialogue.
CannaHealth Summit 2026Who attends
This summit is for everyone at the intersection of cannabis science, clinical medicine, and human performance — including the patients and caregivers who deserve a seat at the table.
The team
Summit Co-Host
Dr. Robert W. Turner II
Associate Professor, Duke University
Summit Co-Host
Rev. Dr. Alvin C. Hathaway
President/CEO, Beloved Community Service Corp.
Lead Clinician
Dr. Jean Talleyrand
Founder, MediCann · Chief Medical Officer, CESC
Lead Scientist
Dr. Harold Han
Founder, PhytoRX · "The Happy Chemist"
Agenda
Morning Session — 8:30 AM to 12:15 PM
Breakfast & Registration
Opening Remarks
Dr. Robert Turner & Dr. Al Hathaway — bridging cannabis science and clinical medicine for underserved communities
Cannabis as Medicine
Dr. Jean Talleyrand — cannabinoid basics & healing mechanisms; clinical outcomes data; risk factors for athletes; the prescription pathway
Morning Break
Drink Your Cannabinoids
Dr. Harold Han — why emulsion bioavailability is the next frontier; solving inconsistency & dosing challenges; clinical applications of water-soluble CBD/CBG
Joint Q&A: Cannabis Science & Medicine
Dr. Talleyrand & Dr. Han answer audience questions live on stage
Afternoon Session — 12:15 PM to 3:30 PM
Lunch & Learn — The Consumer Perspective
A therapeutic cannabis user shares their personal journey — real outcomes, real challenges, and what they want from next-generation products
Panel: Investing in Healing
New regulations, market landscape, rescheduling & CMS implications, and the future of integrative healthcare
Panel: Designing Cannabinoid Care for Real Patient Outcomes
Botanical medicine vs FDA medicine; ideal administration routes; patient-reported outcomes; what an ideal cannabis therapeutic system looks like
Closing Remarks & Networking
Request an invitation
Space is limited. This is a curated summit — attendance is by invitation. Tell us who you are and why you want to be in the room.
Questions? Contact us at
robert.turner2@duke.edu
info@phytorx.co